News from aratana therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 18, 2014, 16:52 ET

Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of...

Dec 16, 2014, 16:28 ET

Aratana Therapeutics Initiates Pivotal Study for AT-003

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Dec 05, 2014, 12:13 ET

Aratana Therapeutics to Present at the 2014 Animal & Dental Health Summit

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of...

Nov 28, 2014, 10:52 ET

Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and...

Nov 17, 2014, 14:12 ET

Aratana Therapeutics to Present at Jefferies Global Healthcare Conference

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of...

Nov 10, 2014, 16:31 ET

Aratana Therapeutics Reports Third Quarter 2014 Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Nov 04, 2014, 16:55 ET

Aratana Therapeutics Inc. to Report Third Quarter Financial Results

 Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Oct 13, 2014, 08:00 ET

Aratana Therapeutics and Atopix Complete Global Licensing Agreement for Development and Commercialization of Novel Atopic Dermatitis Program

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Oct 10, 2014, 09:25 ET

Aratana Therapeutics Announces Presentation of Clinical Data at Annual Veterinary Cancer Society Meeting

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Sep 18, 2014, 18:30 ET

Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Sep 17, 2014, 09:20 ET

Aratana Therapeutics, Inc. Announces Pricing of Public Offering

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Sep 16, 2014, 16:01 ET

Aratana Therapeutics, Inc. Announces Proposed Public Offering

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Sep 09, 2014, 07:00 ET

Aratana Therapeutics Reports Positive Effectiveness Data from Pilot Field Study of Bupivacaine Extended-Release Injectable Suspension (AT-003)

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Sep 05, 2014, 08:15 ET

Aratana Therapeutics to Present at Morgan Stanley Global Healthcare Conference

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Aug 12, 2014, 06:30 ET

Aratana Therapeutics Reports Second Quarter 2014 Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Aug 07, 2014, 17:52 ET

Aratana Therapeutics Appoints Irvine Hockaday to Board of Directors

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Aug 07, 2014, 15:28 ET

Aratana Therapeutics Inc. to Report Second Quarter Financial Results

 Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Jul 02, 2014, 07:30 ET

Aratana Therapeutics Files for USDA Product License of AT-014 Canine Osteosarcoma Immunotherapy

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Jun 23, 2014, 16:01 ET

Aratana Therapeutics Adds Robert P. Roche, Jr. to Board of Directors

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Jun 19, 2014, 16:31 ET

Aratana Therapeutics to Participate in Two Upcoming Investor Conferences

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...